Endogenous endophthalmitis associated with intravenous drug abuse: Seven-year experience at a tertiary referral center

Retina

Volumn 30, Issue 10, 2010, Pages 1721-1725

  Connell, Paul P ^a,b   O'Neill, Evelyn C ^a,b   Amirul Islam, F M ^a   Buttery, Robert ^b   McCombe, Mark ^b   Essex, Rohan H ^b   Roufail, Edward ^b   Lash, Stephen ^b   Wolffe, Bernard ^b   Clark, Ben ^b   Chiu, Daniel ^b   Campbell, William ^a   Allen, Penelope ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; CEFTAZIDIME; VANCOMYCIN;

ADULT; ARTICLE; CANDIDA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOGENOUS FUNGAL ENDOPHTHALMITIS; FEMALE; FUNGAL ENDOPHTHALMITIS; GENDER BIAS; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MICROFLORA; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VITRECTOMY;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; CEFTAZIDIME; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; VANCOMYCIN; VISUAL ACUITY; VITRECTOMY; YOUNG ADULT;

EID: 78650183185     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181dd6db6     Document Type: Article

References (24)

1. Essman TF, Flynn HW, Jr., Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endoph-thalmitis. Ophthalmic Surg Lasers 1997;28:185-194.
2. Feman SS, Nichols JC, Chung SM, Theobald TA. Endoph-thalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 2002;100:67-70; discussion 70-61.
3. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994;101:832-838.
4. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990;162:115-120.
5. Takebayashi K, Matsumoto S, Nakagawa Y, Wakabayashi S, Aso Y, Inukai T. Endogenous endophthalmitis and disseminated intravascular coagulation complicating a Klebsiella pneumoniae perirenal abscess in a patient with type 2 diabetes. Am J Med Sci 2005;329:157-160.
6. Mellinger M, De Beauchamp O, Gallien C, Ingold R, Taboada MJ. Epidemiological and clinical approach to the study of candidiasis caused by Candida albicans in heroin addicts in the Paris region: analysis of 35 observations. Bull Narc 1982;34: 61-81.
7. Bouchez J, Beauverie P, Touzeau D. Substitution with buprenorphine in methadone-and morphine sulfate-dependent patients. Preliminary results. Eur Addict Res 1998;1(Suppl): 8-12.
8. Cassoux N, Bodaghi B, Lehoang P, Edel Y. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex). Br J Ophthalmol 2002;86:940-941.
9. Aboltins CA, Allen P, Daffy, JR. Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species. Med J Aust 2005;182:427.
10. Dupont B, Drouhet E. Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients. J Infect Dis 1985;152:577-591.
11. Leen CL, Brettle RP. Fungal infections in drug users. J Antimicrob Chemother 1991;28(Suppl A):83-96.
12. Hirsbein D, Attal P, Gueudry J, Guet I, Brasseur G, Vasseneix C. Endogenous Candida endophthalmitis in drug misusers injecting intravenous buprenorphine. J Fr Ophtalmol 2008; 31:180-183.
13. Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998;27:1130-1133.
14. Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years' experience from a center in India. Retina 2008;28:1400-1407.
15. Shen X, Xu G. Vitrectomy for endogenous fungal endoph-thalmitis. Ocul Immunol Inflamm 2009;17:148-152.
16. Sowmya P, Madhavan HN. Diagnostic utility of polymerase chain reaction on intraocular specimens to establish the etiology of infectious endophthalmitis. Eur J Ophthalmol 2009;19:812-817.
17. Goldschmidt P, Degorge S, Benallaoua D, et al. New test for the diagnosis of bacterial endophthalmitis. Br J Ophthalmol 2009;93:1089-1095.
18. Goldschmidt P, Ferreira CC, Degorge S, et al. Rapid detection and quantification of Propionibacteriaceae. Br J Ophthalmol 2009;93:258-262.
19. Schelenz S, Goldsmith DJ. Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. J Infect 2003;47:336-343.
20. Smiddy WE. Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol 1998;9:66-70.
21. Williams MA, McMullan R, Hedderwick S, Mulholland DA, Best RM. Diagnosis and treatment of endogenous fungal endophthalmitis. Ophthalmologica 2006;220:134-136.
22. Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol 2006;244:816-820.
23. Keswani T, Ahuja V, Changulani M. Evaluation of outcome of various treatment methods for endogenous endophthalmitis. Indian J Med Sci 2006;60:454-460.
24. Verma L, Patil R, Talwar D, Tewari HK, Ravi K. First contact management of postoperative endophthalmitis. A retrospective analysis. Indian J Ophthalmol 2004;52:65-66.